medigraphic.com

2013, Number 2

<< Back Next >>

Rev Cuba Endoc 2013; 24 (2)

Echocardiographic findings in children and adolescents with type 1 diabetes mellitus

González FP, Ozores SJ, Gutiérrez GCJ

Language: Spanish
References: 40
Page: 176-187
PDF size: 75.13 Kb.


ABSTRACT

Introduction: cardiovascular complications can emerge at early ages in patients with type 1 diabetes mellitus.
Objective: to identify alterations in ventricle function of children and adolescents with type 1 diabetes mellitus.
Methods: a cross-sectional study was conducted in 52 children and adolescents (28 males and 24 females) diagnosed with type 1 diabetes mellitus, aged 2 to 8 years and in 44 non-diabetic subjects (22 males and 22 females) with ages similar to those of the study group. They had been all seen at the endocrinology service of "William Soler" pediatric teaching hospital February 2010 to August 2011 and they were all performed echocardiographic exams using Aloka 5500 equipment and 3,5 and 5 MHz transducers.
Results: there were significant differences in the diastolic function of both ventricles as well as in the systolic function of the right ventricle of patients with type 1 diabetes mellitus in comparison with the controls. Likewise, there was a reversely significant relation with the diastolic function variable of the right ventricle, the length of progression and the ages at diagnosis of type 1 diabetes mellitus.
Conclusions: the alterations in the diastolic and systolic functions compatible with diabetic myocardiopathy are present in children and adolescents with type 1 diabetes mellitus more frequently than in the control group, all of which could be related to the increase in the number of hormones in puberty and the association with autosomal cardiovascular neuropathy.


REFERENCES

  1. Li C, Ford ES, Tsai J, Zhao G, Balluz LS, Gidding SS. Serum non high density lipoprotein cholesterol concentration and risk of death from cardiovascular diseases among U.S. adults with diagnosed diabetes: the third National Health and Nutrition Examination Survey linked mortality study. Cardiovasc Diabetol. 2011;10:46.

  2. Mäkinen VP, Forsblom C, Thorn LM, Wadèn J, Kaski K, Ala-Korpela M, et al. Network of vascular diseases, death and biochemical characteristic in a set of 4,197 patients with type 1 diabetes (The FinnDiane Study). Cardiovasc Diabetol [serie en Internet]. 2009 [citado 18 de noviembre de 2012];8. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763862/

  3. Seuc Armando H, Domínguez Alonso E, Torres Vidal RM, Varona Pérez P. Algunas precisiones acerca de la mortalidad por enfermedades cardiovasculares en Cuba. Rev Cubana Salud Pública [serie en Internet]. 2011 Mar [citado 20 de noviembre de 2012];37(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 34662011000100004&lng=es

  4. Cabrera González RB, Licea Puig ME. Mortalidad en la diabetes mellitus. Rev Cubana Endocrinol [serie en Internet]. 2001 Abr [citado 21 de noviembre de 2012]; 12(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561- 29532001000100001&lng=es

  5. Selvaraju V, Joshi M, Suresh S, Sanchez JA, Maulik N, Maulik G. Diabetes, oxidative stress, molecular mechanism, and cardiovascular disease an overview. Toxicol Mech Methods. 2012;22:330-5.

  6. Zhang X, Chen C. A new insight of mechanisms, diagnosis and treatment of diabetic cardiomyopathy. Endocrine. 2012;41:398-409.

  7. Rivellese AA, Piatti, Italian Intersociety Consensus Group. Consensus on: Screening and therapy of coronary heart disease in diabetic patients. Nutr Metab Cardiovasc Dis. 2011;21:757-64.

  8. Bertoni AG, Tsai A, Kasper EK, Brancati FL. Diabetes and idiopathic cardiomiopathy: a nationwide case-control study. Diabetes Care. 2003;26:2791-5.

  9. Murarka S, Movahed MR. Diabetic cardiomyopathy. J Card Fail. 2010;16:971-9.

  10. Karavanaki K, Kazianis G, Konstantopoulos I, Tsouvalas E, Karayianni C. Early signs of left ventricular dysfunction in adolescents with type 1 diabetes mellitus: the importance of impaired circadian modulation of blood pressure and heart rate. J Endocrinol Invest. 2008;31:289-96.

  11. Vazeou A, Papadopoulou A, Miha M, Drakatos A, Georgacopoulos D. Cardiovascular impairment in children, adolescents, and young adults with type 1 diabetes mellitus (T1DM). Eur J Pediatr. 2008;167:877-84.

  12. Licea Puig M, Singh Linares O, Martínez García R, Díaz Féliz A. Disfunción ventricular izquierda subclínica en diabéticos tipo 1 con menos de 10 años de evolución de la diabetes. Rev Cubana Endocrinol [serie en Internet]. 2001 Abr [citado 21 de noviembre de 2012];12(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561- 29532001000100005&lng=es

  13. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972;30:595-602.

  14. Ernande L, Derumeaux G. Diabetic cardiomyopathy: myth or reality? Arch Cardiovasc Dis. 2012;105:218-25.

  15. An D, Rodrigues B. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol. 2006;291:H1489-H1506.

  16. Poornima IG, Parikh P, Shannon RP. Diabetic cardiomyopathy. The search for a unifying hypothesis. Circ Res. 2006:98:596-605.

  17. El Dayem SM, Battah AA. Effect of glycemic control on the progress of left ventricular hypertrophy and diastolic dysfunction in children with type I diabetes mellitus. Anadolu Kardiyol Derg. 2012;12:498-507.

  18. Tarquini R, Lazzeri C, Pala L, Rotella CM, Gensini GF. The diabetic cardiomyopathy. Acta Diabetol. 2011;48:173-81.

  19. Watanabe K, Thandavarayan RA, Gurusamy N, Zhang S, Muslin AJ, Suzuki K, et al. Role of 14-3-3 protein and oxidative stress in diabetic cardiomyopathy. Acta Physiol Hung. 2009;96:277-87.

  20. Tillquist MN, Maddox TM. Update on diabetic cardiomyopathy: inches forward, miles to go. Curr Diab Rep. 2012;12:305-13.

  21. Van Eldersen SGC, Brandts A, Westenberg JJM, van der Grond, Tamsma JT, van Buchem MA, et al. Aortic stiffness is associated with cardiac function and cerebral small vessel disease in patients with type 1 diabetes mmelitus: assessments by magnetic resonance imaging. Eur Radiol. 2010;20:1132-8.

  22. Shivu GN, Abozguia K, Phan TT, Ahmed I, Weaver R, Narendran P, et al. Increased left ventricular torsion in uncomplicated type 1 diabetic patients. Diabetes Care. 2009;32:1710-2.

  23. Severson DL. Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes. Can J Physiol Pharmacol. 2004;82:813-23.

  24. Salem M, El Behery S, Adly A, Khalil D, El Hadidi E. Early predictors of myocardial disease in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes. 2009;10:513-21.

  25. Lopez L, Colan SD, Frommelt PC, Ensing GJ, Kendall K, Younoszai AK, et al. Recommendations for Quantification Methods During the Performance of a Pediatric Echocardiogram: A Report From the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council. J Am Soc Echocardiogr. 2010;23:465-95.

  26. Maisch B, Alter P, Pankuweit S. Diabetic cardiomyopathy fact or fiction? Herz. 2011;36:102-15.

  27. Giannini C, Mohn A, Chiarelli F, Kelnar CJ. Macrovascular angiopathy in children and adolescents with type 1 diabetes. Diabetes Metab Res Rev. 2011;27:436-60.

  28. González Fernández P, Navarro Despaigne D, González Fernández C. Trastornos de la función cardiorrespiratoria en niños con diabetes mellitus insulinodependientes. Av Diabetol (España). 1994;9:97-102.

  29. Payne JF, Tangpricha V, Cleveland J, Lynn MJ, Ray R, Srivastava SK. Serum insulin-like growth factor-I in diabetic retinopathy. Mol Vis. 2011;17:2318-24.

  30. Kumar PA, Brosius FC 3rd, Menon RK. The glomerular podocyte as a target of growth hormone action: implications for the pathogenesis of diabetic nephropathy. Curr Diabetes Rev. 2011;7:50-5.

  31. Sun J, Devish K, Langer WJ, Carmines PK, Lane PH. Testosterone treatment promotes tubular damage in experimental diabetes in prepubertal rats. Am J Physiol Renal Physiol. 2007;292:F1681-90.

  32. Chen HS, Wu TE, Hsiao LC, Lin SH. Interaction between glycaemic control and serum insulin-like growth factor 1 on the risk of retinopathy in type 2 diabetes. Eur J Clin Invest. 2012;42:447-54

  33. Suys BE, Katier N, Rooman RP, Matthys D, Op De Beeck L, Du Caju MV, et al. Female children and adolescents with type 1 diabetes have more pronounced early echocardiographic signs of diabetic cardiomyopathy. Diabetes Care. 2004 Aug; 27(8):1947-53.

  34. Ruppert K, Roberts MS, Orchard TJ, Zgibor JC. Cardiovascular disease risk prediction in type 1 diabetes: accounting for the differences. Diabetes Res Clin Pract. 2007;78:234-7.

  35. Williams BK, Guelfi KJ, Jones TW, Davis EA. Lower cardiorespiratory fitness in children with Type 1 diabetes. Diabet Med. 2011;28:1005-7.

  36. Stiles MC, Seaquist ER, Yale JF, Green JB, Katz LA, Kempainen S, et al. Is silent myocardial infarction more common in women with type 2 diabetes than in men? J Diabetes Complications. 2012;26:118-22.

  37. O'Neill BT, Abel ED. Akt-1 in the cardiovascular system: friend or foe? J Clin Invest. 2005;115: 2059-64.

  38. Vera Fernández Y, Buchaca Faxas EF, Castro Arca A, Rodríguez Amador L, Bermúdez Rojas S, Alonso Rodríguez C. Hiperglucemia y anormalidades acústicas del tejido miocárdico del paciente con diabetes mellitus. Rev Cubana Med [serie en Internet]. 2007 Sep [citado 20 de noviembre de 2012];46(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034- 75232007000300003&lng=es

  39. Köken R, Demir T, Sen TA, Kundak AA, Oztekin O, Alpay F. The relationship between P-wave dispersion and diastolic functions in diabetic children. Cardiol Young. 2010;20:133-7.

  40. Friedman NE, Levitsky LL, Edidin DV, Vitullo DA, Lacina SJ, Chiemmongkoltip P. Echocardiographic evidence for impaired myocardial performance in children with type 1 diabetes mellitus. Am J Med. 1982;73:846-50.




2020     |     www.medigraphic.com